 L51 |
 |
Erythema multiforme |
| |
| UseAdditionalCode |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
|
| UseAdditionalCode |
code to identify associated manifestations, such as:
arthropathy associated with dermatological disorders (M14.8-)
conjunctival edema (H11.42)
conjunctivitis (H10.22-)
corneal scars and opacities (H17.-)
corneal ulcer (H16.0-)
edema of eyelid (H02.84-)
inflammation of eyelid (H01.8)
keratoconjunctivitis sicca (H16.22-)
mechanical lagophthalmos (H02.22-)
stomatitis (K12.-)
symblepharon (H11.23-)
|
| UseAdditionalCode |
code to identify percentage of skin exfoliation (L49.-)
|
| Excludes1 |
staphylococcal scalded skin syndrome (L00)
Ritter's disease (L00)
|
|
| |
 L51.0 |
|
Nonbullous erythema multiforme |
|
| |
| L51.1 |
|
Stevens-Johnson syndrome |
|
| |
| L51.2 |
|
Toxic epidermal necrolysis [Lyell] |
|
| |
| L51.3 |
|
Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome |
| |
|
|
| |
| L51.8 |
|
Other erythema multiforme |
|
| |
| L51.9 |
|
Erythema multiforme, unspecified |
| |
| Erythema iris | | Erythema multiforme major NOS | | Erythema multiforme minor NOS | | Herpes iris |
|
|